文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Advances in the Optimization of Fe Nanoparticles: Unlocking Antifungal Properties for Biomedical Applications.

作者信息

Sandhu Zeshan Ali, Raza Muhammad Asam, Alqurashi Abdulmajeed, Sajid Samavia, Ashraf Sufyan, Imtiaz Kainat, Aman Farhana, Alessa Abdulrahman H, Shamsi Monis Bilal, Latif Muhammad

机构信息

Department of Chemistry, Faculty of Science, Hafiz Hayat Campus, University of Gujrat, Gujrat 50700, Pakistan.

Department of Biology, College of Science, Taibah University, Madinah 42353, Saudi Arabia.

出版信息

Pharmaceutics. 2024 May 10;16(5):645. doi: 10.3390/pharmaceutics16050645.


DOI:10.3390/pharmaceutics16050645
PMID:38794307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11124843/
Abstract

In recent years, nanotechnology has achieved a remarkable status in shaping the future of biological applications, especially in combating fungal diseases. Owing to excellence in nanotechnology, iron nanoparticles (Fe NPs) have gained enormous attention in recent years. In this review, we have provided a comprehensive overview of Fe NPs covering key synthesis approaches and underlying working principles, the factors that influence their properties, essential characterization techniques, and the optimization of their antifungal potential. In addition, the diverse kinds of Fe NP delivery platforms that command highly effective release, with fewer toxic effects on patients, are of great significance in the medical field. The issues of biocompatibility, toxicity profiles, and applications of optimized Fe NPs in the field of biomedicine have also been described because these are the most significant factors determining their inclusion in clinical use. Besides this, the difficulties and regulations that exist in the transition from laboratory to experimental clinical studies (toxicity, specific standards, and safety concerns) of Fe NPs-based antifungal agents have been also summarized.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/b5e78c4b39de/pharmaceutics-16-00645-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/36eb19c1cc8d/pharmaceutics-16-00645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/73f700dab4fa/pharmaceutics-16-00645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/238e43b4a639/pharmaceutics-16-00645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/f0962b35dd71/pharmaceutics-16-00645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/00b96bf1ca80/pharmaceutics-16-00645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/ffc0ea6a76dc/pharmaceutics-16-00645-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/8d9a98aaa26e/pharmaceutics-16-00645-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/08c42116488f/pharmaceutics-16-00645-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/791bbf80aee5/pharmaceutics-16-00645-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/9fcbb01b54f6/pharmaceutics-16-00645-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/f865feb69ea5/pharmaceutics-16-00645-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/801671fd0124/pharmaceutics-16-00645-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/fd537e6ec187/pharmaceutics-16-00645-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/f3de89fd3199/pharmaceutics-16-00645-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/9bcf57912cae/pharmaceutics-16-00645-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/fb211f1fb3c3/pharmaceutics-16-00645-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/1a9ee10c6e72/pharmaceutics-16-00645-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/8f1789a43333/pharmaceutics-16-00645-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/bfa5370ae43d/pharmaceutics-16-00645-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/6e19c23bd2a0/pharmaceutics-16-00645-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/4b20997069f6/pharmaceutics-16-00645-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/e0fd94750b1e/pharmaceutics-16-00645-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/eb0e68e85345/pharmaceutics-16-00645-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/3832d3388049/pharmaceutics-16-00645-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/b5e78c4b39de/pharmaceutics-16-00645-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/36eb19c1cc8d/pharmaceutics-16-00645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/73f700dab4fa/pharmaceutics-16-00645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/238e43b4a639/pharmaceutics-16-00645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/f0962b35dd71/pharmaceutics-16-00645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/00b96bf1ca80/pharmaceutics-16-00645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/ffc0ea6a76dc/pharmaceutics-16-00645-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/8d9a98aaa26e/pharmaceutics-16-00645-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/08c42116488f/pharmaceutics-16-00645-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/791bbf80aee5/pharmaceutics-16-00645-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/9fcbb01b54f6/pharmaceutics-16-00645-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/f865feb69ea5/pharmaceutics-16-00645-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/801671fd0124/pharmaceutics-16-00645-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/fd537e6ec187/pharmaceutics-16-00645-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/f3de89fd3199/pharmaceutics-16-00645-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/9bcf57912cae/pharmaceutics-16-00645-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/fb211f1fb3c3/pharmaceutics-16-00645-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/1a9ee10c6e72/pharmaceutics-16-00645-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/8f1789a43333/pharmaceutics-16-00645-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/bfa5370ae43d/pharmaceutics-16-00645-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/6e19c23bd2a0/pharmaceutics-16-00645-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/4b20997069f6/pharmaceutics-16-00645-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/e0fd94750b1e/pharmaceutics-16-00645-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/eb0e68e85345/pharmaceutics-16-00645-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/3832d3388049/pharmaceutics-16-00645-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b96f/11124843/b5e78c4b39de/pharmaceutics-16-00645-g025.jpg

相似文献

[1]
Advances in the Optimization of Fe Nanoparticles: Unlocking Antifungal Properties for Biomedical Applications.

Pharmaceutics. 2024-5-10

[2]
Synthesis, biomedical applications, and toxicity of CuO nanoparticles.

Appl Microbiol Biotechnol. 2023-2

[3]
Synthesis, physical properties, and biomedical applications of magnetic nanoparticles: a review.

Prog Biomater. 2022-12

[4]
A review of small molecules and drug delivery applications using gold and iron nanoparticles.

Int J Nanomedicine. 2019-3-11

[5]
Synthesis and Biomedical Applications of Multifunctional Nanoparticles.

Adv Mater. 2018-8-21

[6]
Algal-derived nanoparticles and their antibacterial potential: Current evidence and future prospectives.

J Microbiol Methods. 2023-8

[7]
Insights into Characterization Methods and Biomedical Applications of Nanoparticle-Protein Corona.

Materials (Basel). 2020-7-10

[8]
Biomedical applications of cerium vanadate nanoparticles: a review.

J Mater Chem B. 2024-1-17

[9]
Green and cost-effective biofabrication of copper oxide nanoparticles: Exploring antimicrobial and anticancer applications.

Biotechnol Rep (Amst). 2024-1-12

[10]
Functional DNA Molecules Enable Selective and Stimuli-Responsive Nanoparticles for Biomedical Applications.

Acc Chem Res. 2019-8-14

引用本文的文献

[1]
Functionalized Silver Nanoparticles as Multifunctional Agents Against Gut Microbiota Imbalance and Inflammation.

Nanomaterials (Basel). 2025-5-28

[2]
Three-Dimensional Printable Magnetic Hydrogels with Adjustable Stiffness and Adhesion for Magnetic Actuation and Magnetic Hyperthermia Applications.

Gels. 2025-1-15

[3]
Liver-targeting iron oxide nanoparticles and their complexes with plant extracts for biocompatibility.

Beilstein J Nanotechnol. 2024-12-11

[4]
Biomimetic Antifungal Materials: Countering the Challenge of Multidrug-Resistant Fungi.

Biomimetics (Basel). 2024-7-12

本文引用的文献

[1]
Application of Nanoparticles for Magnetic Hyperthermia for Cancer Treatment-The Current State of Knowledge.

Cancers (Basel). 2024-3-14

[2]
Antifungal activity of FeO@SiO/Schiff-base/Cu(II) magnetic nanoparticles against pathogenic Candida species.

Sci Rep. 2024-3-11

[3]
Recent development of pH-responsive theranostic nanoplatforms for magnetic resonance imaging-guided cancer therapy.

Exploration (Beijing). 2023-3-30

[4]
Conjugated Nanoparticles for Solid Tumor Theranostics: Unraveling the Interplay of Known and Unknown Factors.

ACS Omega. 2023-10-5

[5]
Metallic Nanoparticles: A Promising Arsenal against Antimicrobial Resistance-Unraveling Mechanisms and Enhancing Medication Efficacy.

Int J Mol Sci. 2023-10-4

[6]
Recent developments in photodynamic therapy and its application against multidrug resistant cancers.

Biomed Mater. 2023-10-24

[7]
Magnetic Nanoparticles: A Review on Synthesis, Characterization, Functionalization, and Biomedical Applications.

Small. 2024-2

[8]
Magnetic Resonance Imaging and Iron-oxide Nanoparticles in the era of Personalized Medicine.

Nanotheranostics. 2023

[9]
A comprehensive review on potential applications of metallic nanoparticles as antifungal therapies to combat human fungal diseases.

Saudi Pharm J. 2023-9

[10]
Advances in preparation, biomedical, and pharmaceutical applications of chitosan-based gold, silver, and magnetic nanoparticles: A review.

Int J Biol Macromol. 2023-11-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索